Daratumumab(HuMax®-CD38)Safety Study in Multiple Myeloma
This study is currently recruiting participants.
Verified March 2013 by Genmab
Sponsor:
Genmab
Information provided by (Responsible Party):
Genmab
ClinicalTrials.gov Identifier:
NCT00574288
First received: December 14, 2007
Last updated: March 4, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | April 2015 |
| Estimated Primary Completion Date: | July 2013 (Final data collection date for primary outcome measure) |